Stanley Capital to buy Noden from PDL BioPharma
PDL BioPharma Inc has agreed to sell Noden to Stanley Capital for up to $48.25 million in cash.
30 July 2020•4 mins read
PDL BioPharma Inc has agreed to sell Noden to Stanley Capital for up to $48.25 million in cash.
LLCP bullish on loan services following GLAS sale to Oakley Capital
59 minutes ago · 2 mins read
Butterfly Equity sees food packaging as essential after debuting in sector
1 hour ago · 3 mins read
Heartwood Partners’ NativeSeed Group acquires assets of Kansas seed cleaner Sharp Brothers
1 hour ago · 1 min read
Arcline’s Signia Aerospace to acquire JLL Partners’ Heads Up Technologies
2 hours ago · 1 min read
Ansor’s Corvero acquires Northern Ireland aerospace tooling specialist Datum Design
3 hours ago · 2 mins read
HIG Capital’s Vernacare adds UK medical device businesses Bailey and ASep
5 hours ago · 2 mins read
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
21 hours ago · 1 min read
